AVA TherapeutiX

AVA TherapeutiX

AVA-NextGenMonoclonalsTM identified in AVA NewTechnology are further developed in AVATherapeutiX for precision therapy approaches. The focus is not only on their direct use as therapeutic AVA-mAbsTM, but also on the use of mAb derivatives. In particular, CAR-T-cell based immunotherapy is at the center of our interest.

Image